VEGFR-TKIs: Nurse management of adverse events

December 06, 2023 00:12:56
VEGFR-TKIs: Nurse management of adverse events
COR2ED - Oncology Medical Conversation
VEGFR-TKIs: Nurse management of adverse events

Dec 06 2023 | 00:12:56

/

Show Notes

In this podcast, Veerle Lamotte, an oncology nurse practitioner at Antwerp University Hospital and Paola Belardi, nurse chief at San Donato Hospital in Arezzo, Italy discuss the role of the nurse in the management of adverse events in patients receiving VEGFR-TKI treatment. Their discussion focuses specifically on patients with hepatocellular cancer (HCC), differentiated thyroid cancer and advanced renal cell carcinoma (RCC).

VEGFR-TKIs are widely used treatments for these solid tumours but are associated with substantial toxicity which needs early recognition and management in order to help patients stay on optimal treatment.

The most common adverse events related to these treatments are discussed together with recommendations for their management. Veerle and Paola discuss the key role of the nurse as part of the multi-disciplinary team involved in the patient’s care, and the role they have in providing close support and guidance to the patient. Education of patients regarding potential side effects and early identification and management of adverse events is key in terms of trying to keep patients on the optimum dose so that they can achieve the best outcomes.

Other Episodes

Episode

December 06, 2023 00:21:48
Episode Cover

Prostate cancer: Radiopharmaceuticals. Part 2 - PSMA theranostics

Dr. Tanya Dorff (City of Hope Comprehensive Cancer Center, Los Angeles, USA) and Dr. Phillip Koo (Banner MD Anderson Cancer Center, Arizona, USA) discuss...

Listen

Episode

December 06, 2023 00:19:20
Episode Cover

Colorectal and gastric cancer: Current and future therapeutic approaches. Part 1 - Targeted therapy

In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité...

Listen

Episode

December 06, 2023 00:23:12
Episode Cover

Breast cancer: Oral SERDs in ER+ BC. Part 1 - Efficacy, safety and the treatment landscape

In this podcast, the experts give an overview of  the EMERALD trial  and present elacestrant as the first, and currently only, oral SERD to...

Listen